Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 4192483, 17 pages
http://dx.doi.org/10.1155/2016/4192483
Research Article

The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat Model

1Department of Pharmacognosy, West China College of Pharmacy, Sichuan University, No. 17, Duan 3, Renmin Nan Road, Chengdu 610041, China
2Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria

Received 28 February 2016; Accepted 20 June 2016

Academic Editor: Seong-Gyu Ko

Copyright © 2016 Dongdong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Spurzem and S. I. Rennard, “Pathogenesis of COPD,” Seminars in Respiratory and Critical Care Medicine, vol. 26, no. 2, pp. 142–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. F. Rabe, S. Hurd, A. Anzueto et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 6, pp. 532–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Ginter, “World Health Report 2000: the position of Slovak Republic,” Bratislavske Lekarske Listy, vol. 101, no. 9, pp. 477–483, 2000. View at Google Scholar · View at Scopus
  4. A. D. Lopez and C. C. J. L. Murray, “The global burden of disease, 1990–2020,” Nature Medicine, vol. 4, no. 11, pp. 1241–1243, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. W. MacNee, “Pathogenesis of chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 2, no. 4, pp. 258–266, 2005. View at Publisher · View at Google Scholar
  6. T. L. Hackett, D. A. Knight, and D. D. Sin, “Potential role of stem cells in management of COPD,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 5, no. 1, pp. 81–88, 2010. View at Google Scholar · View at Scopus
  7. I. K. Demedts, T. Demoor, K. R. Bracke, G. F. Joos, and G. G. Brusselle, “Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema,” Respiratory Research, vol. 7, article 53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. L. G. Mahtaj, A. Feizpour, M. Kianmehr, M. Soukhtanloo, and M. H. Boskabady, “The effect of carvacrol on systemic inflammation in guinea pigs model of COPD induced by cigarette smoke exposure,” Pharmacological Reports, vol. 67, no. 1, pp. 140–145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Pauwels, A. S. Buist, P. M. A. Calverley, C. R. Jenkins, and S. S. Hurd, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: national Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary,” Respiratory Care, vol. 46, no. 8, pp. 798–825, 2001. View at Google Scholar · View at Scopus
  10. R. A. Pauwels, A. S. Buist, P. M. A. Calverley, C. R. Jenkins, and S. S. Hurd, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1256–1276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Drost, K. M. Skwarski, J. Sauleda et al., “Oxidative stress and airway inflammation in severe exacerbations of COPD,” Thorax, vol. 60, no. 4, pp. 293–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. MacNee, “Oxidative stress and lung inflammation in airways disease,” European Journal of Pharmacology, vol. 429, no. 1–3, pp. 195–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Yamamoto, T. Yoneda, M. Yoshikawa et al., “Airway inflammation in COPD assessed by sputum levels of interleukin-8,” Chest, vol. 112, no. 2, pp. 505–510, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. L. J. Xu, R. J. Dandurand, M. Lei, and D. H. Eidelman, “Airway hyperresponsiveness in cigarette smoke-exposed rats,” Lung, vol. 171, no. 2, pp. 95–107, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. P. J. Barnes, “New concepts in chronic obstructive pulmonary disease,” Annual Review of Medicine, vol. 54, pp. 113–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Barnes, “Chronic obstructive pulmonary disease 12: new treatments for COPD,” Thorax, vol. 58, no. 9, pp. 803–808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Boskabady and L. Gholami Mhtaj, “Effect of the Zataria multiflora on systemic inflammation of experimental animals model of COPD,” BioMed Research International, vol. 2014, Article ID 802189, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Barnes, “Immunology of asthma and chronic obstructive pulmonary disease,” Nature Reviews Immunology, vol. 8, no. 3, pp. 183–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-Y. Lacoste, J. Bousquet, P. Chanez et al., “Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease,” The Journal of Allergy and Clinical Immunology, vol. 92, no. 4, pp. 537–548, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Vestbo, S. S. Hurd, A. G. Agustí et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 4, pp. 347–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Tantucci and D. Modina, “Lung function decline in COPD,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 7, pp. 95–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Hogg, F. Chu, S. Utokaparch et al., “The nature of small-airway obstruction in chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 350, no. 26, pp. 2645–2653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. E. L. Hardaker, M. S. Freeman, N. Dale et al., “Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung,” British Journal of Pharmacology, vol. 160, no. 8, pp. 1985–1996, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zhou, X. Tan, W. Kuang, L. Liu, and L. Wan, “Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats,” Translational Research, vol. 159, no. 6, pp. 464–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-C. Nie, H. Wu, P.-B. Li et al., “Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease,” Pulmonary Pharmacology & Therapeutics, vol. 25, no. 5, pp. 349–356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Hele and M. G. Belvisi, “Novel therapies for the treatment of inflammatory airway disease,” Expert Opinion on Investigational Drugs, vol. 12, no. 1, pp. 5–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Barnes and T. T. Hansel, “Prospects for new drugs for chronic obstructive pulmonary disease,” The Lancet, vol. 364, no. 9438, pp. 985–996, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. Y.-C. Park, M. Jin, S.-H. Kim, M.-H. Kim, U. Namgung, and Y. Yeo, “Effects of inhalable microparticle of flower of Lonicera japonica in a mouse model of COPD,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 123–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Decramer, V. de Bock, and R. Dom, “Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 6, pp. 1958–1964, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. The Lung Health Study Research Group, “Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 343, no. 26 I, pp. 1902–1909, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Lixuan, D. Jingcheng, Y. Wenqin, H. Jianhua, L. Baojun, and F. Xiaotao, “Baicalin attenuates inflammation by inhibiting NF-κB activation in cigarette smoke induced inflammatory models,” Pulmonary Pharmacology and Therapeutics, vol. 23, no. 5, pp. 411–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Zhang, L. Feng, M. Li, C. Dong, and W. Zhang, “Effects of Xiaoqinglong decoction on gene expression profiles in a rat chronic obstructive pulmonary disease model,” BioScience Trends, vol. 6, no. 5, pp. 262–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. D.-D. Wang, Y. Feng, Z. Li et al., “In vitro and in vivo antitumor activity of bulbus Fritillariae cirrhosae and preliminary investigation of its mechanism,” Nutrition and Cancer, vol. 66, no. 3, pp. 441–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Li, J. Liu, X. Gong, X. Yang, Y. Zhu, and Z. Cheng, “Characterizing the major morphological traits and chemical compositions in the bulbs of widely cultivated Fritillaria species in China,” Biochemical Systematics and Ecology, vol. 46, pp. 130–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Wang, J. Zhu, S. Wang et al., “Antitussive, expectorant and anti-inflammatory alkaloids from Bulbus Fritillariae Cirrhosae,” Fitoterapia, vol. 82, no. 8, pp. 1290–1294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Wang, S. Wang, X. Chen et al., “Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 189–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. D. G. Kang, E. J. Sohn, Y. M. Lee et al., “Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats,” Journal of Ethnopharmacology, vol. 91, no. 1, pp. 51–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Wang, S. Wang, Y. Feng et al., “Antitumor effects of Bulbus Fritillariae cirrhosae on Lewis lung carcinoma cells in vitro and in vivo,” Industrial Crops and Products, vol. 54, pp. 92–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Li, C. Xu, Q. Zhang, J. Y. Liu, and R. X. Tan, “In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases,” Journal of Ethnopharmacology, vol. 98, no. 3, pp. 329–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. R. M. Eglen, G. C. Harris, H. Cox, A. O. Sullivan, E. Stefanich, and R. L. Whiting, “Characterization of the interaction of the cervane alkaloid, imperialine, at muscarinic receptors in vitro,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 346, no. 2, pp. 144–151, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. Atta-ur-Rahman, M. I. Choudhary, A. Farooq, S. Anjum, J. Baumgold, and B. Sener, “Structure-activity relationships of imperialine derivatives and their anticholinergic activity,” Planta Medica, vol. 64, no. 2, pp. 172–174, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Rajendrasozhan, J.-W. Hwang, H. Yao, N. Kishore, and I. Rahman, “Anti-inflammatory effect of a selective IκB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke,” Pulmonary Pharmacology and Therapeutics, vol. 23, no. 3, pp. 172–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Li, S.-Y. Li, J.-S. Li et al., “A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection,” Biological & Pharmaceutical Bulletin, vol. 35, no. 10, pp. 1752–1760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Domínguez-Fandos, C. Valdés, E. Ferrer et al., “Sildenafil in a cigarette smoke-induced model of COPD in the guinea-pig,” The European Respiratory Journal, vol. 46, no. 2, pp. 346–354, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Wang, X. Jiang, L. Zhang, L. Wang, Z. Li, and W. Sun, “Simvastatin mitigates functional and structural impairment of lung and right ventricle in a rat model of cigarette smoke-induced COPD,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 12, pp. 8553–8562, 2014. View at Google Scholar · View at Scopus
  46. S. Kubo, M. Kobayashi, Y. Masunaga et al., “Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs,” The European Respiratory Journal, vol. 26, no. 6, pp. 993–1001, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Barberà, V. I. Peinado, S. Santos, J. Ramirez, J. Roca, and R. Rodriguez-Roisin, “Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 4, pp. 709–713, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Gholami Mahtaj, M. H. Boskabady, and N. Mohamadian Roshan, “The effect of Zataria multiflora and its constituent, carvacrol, on tracheal responsiveness and lung pathology in guinea pig model of COPD,” Phytotherapy Research, vol. 29, no. 5, pp. 730–736, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Zhou, J. L. Wright, J. Liu, D. D. Sin, and A. Churg, “Aging does not enhance experimental cigarette smoke-induced COPD in the mouse,” PLoS ONE, vol. 8, no. 8, Article ID e71410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. Y.-F. Wan, Z.-H. Huang, K. Jing et al., “Azithromycin attenuates pulmonary inflammation and emphysema in smoking-induced COPD model in rats,” Respiratory Care, vol. 60, no. 1, pp. 128–134, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Herr, G. Han, D. Li et al., “Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model,” Experimental and Toxicologic Pathology, vol. 67, no. 3, pp. 261–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. L.-L. Shen, Y.-N. Liu, H.-J. Shen et al., “Inhalation of glycopyrronium inhibits cigarette smoke-induced acute lung inflammation in a murine model of COPD,” International Immunopharmacology, vol. 18, no. 2, pp. 358–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Zheng, Y. Liu, T. Huang, Z. Fang, G. Li, and S. He, “Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke,” Toxicology Letters, vol. 189, no. 3, pp. 225–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Papi, C. M. Bellettato, F. Braccioni et al., “Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 10, pp. 1114–1121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Sethi and T. F. Murphy, “Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review,” Clinical Microbiology Reviews, vol. 14, no. 2, pp. 336–363, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. A. M. W. J. Schols, J. Slangen, L. Volovics, and E. F. M. Wouters, “Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1791–1797, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. H. R. Gosker, N. H. M. K. Lencer, F. M. E. Franssen, G. J. Van Der Vusse, E. F. M. Wouters, and A. M. W. J. Schols, “Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD,” Chest, vol. 123, no. 5, pp. 1416–1424, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Yao, I. Edirisinghe, S.-R. Yang et al., “Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice,” The American Journal of Pathology, vol. 172, no. 5, pp. 1222–1237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. L. Simpson, S. Phipps, and P. G. Gibson, “Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis,” Pharmacology & Therapeutics, vol. 124, no. 1, pp. 86–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. M. P. Andersen, A. R. Parham, J. C. Waldrep, W. N. McKenzie, and R. Dhand, “Alveolar fractal box dimension inversely correlates with mean linear intercept in mice with elastase-induced emphysema,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 7, pp. 235–243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Ochs, J. R. Nyengaard, A. Jung et al., “The number of alveoli in the human lung,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 1, pp. 120–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. B.-L. Luo, R.-C. Niu, J.-T. Feng, C.-P. Hu, X.-Y. Xie, and L.-J. Ma, “Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-β/Smads signaling pathways,” Archives of Medical Research, vol. 39, no. 4, pp. 388–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. P. K. Jeffery, “Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease,” The American Review of Respiratory Disease, vol. 143, no. 5, pp. 1152–1161, 1991. View at Publisher · View at Google Scholar · View at Scopus
  64. G. A. Finlay, M. D. O'Donnell, C. M. O'Connor, J. P. Hayes, and M. X. FitzGerald, “Elastin and collagen remodeling in emphysema. A scanning electron microscopy study,” The American Journal of Pathology, vol. 149, no. 4, pp. 1405–1415, 1996. View at Google Scholar · View at Scopus
  65. M. R. Lang, G. W. Fiaux, M. Gillooly, J. A. Stewart, D. J. S. Hulmes, and D. Lamb, “Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs,” Thorax, vol. 49, no. 4, pp. 319–326, 1994. View at Publisher · View at Google Scholar · View at Scopus
  66. W. I. De Boer, A. Van Schadewijk, J. K. Sont et al., “Transforming growth factor β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 6, pp. 1951–1957, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Yao, J.-W. Hwang, I. K. Sundar et al., “SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 305, no. 9, pp. L615–L624, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. M. M. Gueders, J.-M. Foidart, A. Noel, and D. D. Cataldo, “Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases,” European Journal of Pharmacology, vol. 533, no. 1–3, pp. 133–144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. P. K. Srivastava, S. G. Dastidar, and A. Ray, “Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy,” Expert Opinion on Investigational Drugs, vol. 16, no. 7, pp. 1069–1078, 2007. View at Publisher · View at Google Scholar · View at Scopus